Processa Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Processa Pharmaceuticals

09/11/2022 07:15

* Processa Pharmaceuticals Inc  PCSA.OQ  reported a
quarterly
adjusted loss of 37 cents​​ per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for a loss of 34 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Processa Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 37 cents​.
    * The mean earnings estimate of analysts had fallen by
about 55.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Processa Pharmaceuticals Inc shares had fallen by 4.9%
this
quarter and lost 56.1% so far this year.
    * The company reported a quarterly loss of $6.02 million.
    * Wall Street's median 12-month price target for Processa
Pharmaceuticals Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 07:15 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.34          -0.37          Missed
 Jun. 30 2022      -0.20          -0.32          Missed
 Mar. 31 2022      -0.21          -0.20          Beat
 Dec. 31 2021      -0.19          -0.21          Missed